Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05456841 · ClinicalTrials.gov registry record · NA

Empathic Communication Skills (ECS) Training

A NA study of Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
1,232
Enrollment target
12
Study locations

NCT05456841 is a NA study of Lung Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,232 participants, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (32% higher). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05456841, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
1,232 participants
Enrollment target
12
Study locations

Study Summary

Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.

Conditions Studied

Lung Cancer

Interventions

  • BEHAVIORAL Empathic Communication Skills (ECS) training
  • OTHER Standard of Care participant interaction

Study Locations (12)

Pennsylvania

  • Virtua Health (Data Collection Only) - Philadelphia
  • University of Pennsylvania (Data Collection Only) - Philadelphia
  • Fox Chase Cancer Center (Data Collection Only) - Philadelphia

New York

  • Roswell Park Cancer Institute (Data Collection Only) - Buffalo
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York

California

  • Providence St. Joseph Health (Data Collection Only) - Irvine

Florida

  • BAPTIST ALLIANCE - MCI (Data Collection Only) - Miami

Illinois

  • Advocate Health Care Network - Libertyville

Kentucky

  • University of Kentucky (Data Collection Only) - Lexington

Michigan

  • Munson Healthcare (Data Collection Only) - Traverse City

New Jersey

  • Hackensack Meridian Health (Data collection only) - Hackensack

Trial Details

FieldValue
Enrollment Target 1,232 participants
Start Date 2023-04-28
Est. Completion 2026-08-31
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05456841

The ClinicalTrials.gov registry entry for NCT05456841 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,232 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 933-participant average among 409 other Lung Cancer trials with a reported enrollment target (32% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Empathic Communication Skills (ECS) training is the first listed.

NCT05456841 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Pennsylvania, New York, California.

Frequently Asked Questions

What is clinical trial NCT05456841 about?

NCT05456841 is a clinical study titled "Empathic Communication Skills (ECS) Training". Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma w...

What is the current status of trial NCT05456841?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,232 participants. The study started on 2023-04-28. Estimated completion is 2026-08-31.

What conditions does trial NCT05456841 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT05456841?

The interventions under investigation include: Empathic Communication Skills (ECS) training (BEHAVIORAL), Standard of Care participant interaction (OTHER).

Who is sponsoring clinical trial NCT05456841?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05456841 being conducted?

This trial has 12 study locations across California, Florida, Illinois, Kentucky, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.